Sunday, March 02, 2025 | 11:04 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Continue hydroxychloroquine as preventive therapy against Covid-19: ICMR

So far, only high-risk individuals, including asymptomatic health care workers, were given the drug along with household contacts of Covid patients

Hydroxychloroquine, coronavirus, covid-19, drug, drugs, pharma, pharmaceutical
Premium

The conclusion has been drawn after three studies by the ICMR, and as result, it issued an advisory to expand the use of HCQ as a preventive therapy.

Sohini Das Mumbai
While a global debate rages around the efficacy and safety of hydroxychloroquine (HCQ) as a preventive therapy against coronavirus, India’s apex health research body, the Indian Council of Medical Research (ICMR), has found that consuming HCQ reduces the chances of getting infected with Covid-19.

The conclusion has been drawn after three studies by the ICMR, and as result, it issued an advisory to expand the use of HCQ as a preventive therapy.

The joint monitoring group, under the chairmanship of Director General of Health Services (DGHS), and including representatives from the All India Institute of Medical Sciences (AIIMS), ICMR, National

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in